Epistaxis

EMA - Emergency Medicine Australasia

Volumn 16, Issue 5-6, 2004, Pages 428-440

  Middleton, Paul M ^a,b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Western Hospital   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Bleeding; Blood loss; Epistaxis; Haemorrhage; Nose; Nosebleed

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; CALCIUM ALGINATE; CHLORHEXIDINE; COCAINE; COPHENYLOCAINE; DIPYRIDAMOLE; FIBRIN GLUE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MICROCRYSTALLINE COLLAGEN; NEOMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXIDIZED REGENERATED CELLULOSE; OXYMETAZOLINE; POLYVINYL DERIVATIVE; SILVER NITRATE; TRIAMCINOLONE; UNCLASSIFIED DRUG; WARFARIN;

AFTERCARE; AGE; ALCOHOL CONSUMPTION; ANEURYSM; ANTIBIOTIC PROPHYLAXIS; BLEEDING TENDENCY; CAUTERIZATION; COMPRESSION THERAPY; DRUG INDUCED DISEASE; EMERGENCY TREATMENT; ENTEROBACTER; ENVIRONMENTAL FACTOR; EPISTAXIS; FIRST AID; HEAD POSITION; HUMAN; HYPERTENSION; INCIDENCE; MEDLINE; MELANOMA; NASOPHARYNX FIBROMA; NOSE INJURY; NOSE SEPTUM; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEUS MIRABILIS; RESUSCITATION; REVIEW; RISK FACTOR; SQUAMOUS CELL CARCINOMA; STAPHYLOCOCCUS AUREUS; SUCTION DRAINAGE; SURGICAL ANATOMY; SURGICAL SPONGE; TREATMENT PLANNING; UPPER RESPIRATORY TRACT INFECTION; VASOCONSTRICTION;

EID: 9244238646     PISSN: 17426731     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-6723.2004.00646.x     Document Type: Review

References (55)

1. Pothula V, Alderson D. Nothing new under the sun: The management of epistaxis. J. Laryng. Otol. 1998; 112: 331-4.
2. Shaheen OH. Arterial epistaxis. J. Laryngol. Otol. 1975; 89: 17-34.
3. Petruson B. Epistaxis in childhood. Rhinology 1979; 17: 83-90.
4. Beran M, Petruson B. Occurrence of epistaxis in habitual nose-bleeders and analysis of some etiological factors. J. Otol. Rhinol. Laryngol. 1986; 48: 297-303.
5. Strachan D, England J. First-aid treatment of epistaxis - confirmation of widespread ignorance. Postgrad. Med. J. 1998; 74: 113-14.
6. McGarry GW, Moulton C. The first aid management of epistaxis by accident and emergency department staff. Arch. Emerg. Med. 1993; 10: 298-300.
7. Rothenhaus T. Epistaxis. eMediane May 21, 2003 [cited Aug 2003.] Available from URL: http://www.emedicine.com/emerg/topic806.htm/
8. Alvi A, Joyner-Triplett N. Acute epistaxis: How to spot the source and stop the flow. Postgrad. Med. 1996; 99: 83-96.
9. Tomkinson A, Bremmer-Smith A, Craven C, Roblin DG. Hospital epistaxis rate and ambient temperature. Clin. Otolaryngol. 1995; 20: 239-40.
10. Viducich RA, Blanda MP, Gerson LW. Posterior epistaxis: clinical features and acute complications. Ann. Emerg. Med. 1995; 25: 592-6.
11. Manfredini R, Portaluppi F, Salmi R, Martini A, Gallerani M. Circadian variation in onset of epistaxis: analysis of hospital admissions. BMJ 2000; 321: 1112.
12. Santos PM, Lepore ML. Epistaxis. In: Bailey BJ, Healy GB, Johnson JT et al. (eds). Head and Neck Surgery - Otolaryngology. Philadelphia: Lippincott, Williams & Wilkins, 2001; ch 36.
13. Keen MS, Moran WJ. Control of epistaxis in the multiple trauma patient. Laryngoscope 1985; 95: 874-5.
14. Tan LKS, Calhoun KH, Epistaxis. Med. Clin. North Am. 1999; 83: 43-56.
15. Herkner H, Laggner AN, Müllner M et al. Hypertension in patients presenting with epistaxis. Ann. Emerg. Med. 2000; 35: 126-30.
16. Herkner H, Havel C, Mullner M et al. Active epistaxis at ED presentation is associated with arterial hypertension. Am. J. Emerg. Med. 2002; 20: 92-5.
17. McGarry GW, Gatehouse S, Hinnie J. Relation between alcohol and nose bleeds. BMJ 1994; 309: 640.
18. Watson MG, Shenoi PM. Drug-induced epistaxis? J. R. Soc. Med. 1990; 83: 162-4.
19. McGarry GW. Drug induced epistaxis? J. R. Soc. Med. 1990; 83: 165.
20. American College of Surgeons. Advanced Trauma Life Support, 6th edn. Chicago: American College of Surgeons, 1997.
21. Dost P, Polyzoidis T. Benefit of the ice pack in the treatment of nosebleed. HNO 1992; 40: 25-7.
22. Peretta LJ, Denslow BL, Brown CG. Emergency evaluation and management of epistaxis. Emerg. Med. Clin. North Am. 1987; 5: 265-77.
23. London SD. A reliable medical treatment for recurrent mild anterior epistaxis. Laryngoscope 1999; 109: 1535-7.
24. Hutchison SM, Finlayson ND. Epistaxis as a cause of hematemesis and melena. J. Clin. Cast. 1987; 9: 283-5.
25. Johal SS, Austin AS, Ryder SD. Epistaxis: an overlooked cause of massive haematemesis in cirrhosis. BMJ 2003; 326: 440-1.
26. Sabba HI, Morelli GA, Logrono LA. Brief report: Treatment of bleeding in hereditary hemorrhagic telangectasia with aminocaproic acid. N. Engl. J. Med. 1994; 330: 1789-90.
27. Saba HI, Morelli GA, Logrono LA. Comment in: N. Engl. J. Med. 1994; 330: 1822-3.
28. Holland S, Thaha MA, Nilssen EL, White PS. Coagulation studies in patients admitted with epistaxis - current practice in Scotland. J. Laryngol. Otol. 1999; 113: 1086-8.
29. Thaha MA, Nilssen EL, Holland S, Love G, White PS. Routine coagulation screening in the management of emergency admission for epistaxis - is it necessary? J. Laryngol. Otol. 2000; 114: 38-40.
30. Denholm SW, Maynard CA, Watson HG. Warfarin and epistaxis - a case controlled study. J. Laryngol Otol. 1993; 107: 195-6.
31. Srinivasan V, Patel H, John DG, Worsley A. Warfarin and epistaxis: should warfarin always be discontinued? Clin. Otolaryngol. 1997; 22: 542-4.
32. Tay HL, Evans JM, McMahon AD, MacDonald TM. Aspirin, nonsteroidal anti-inflammatory drugs, and epistaxis. A regional record linkage case control study. Ann. Otol. Rhinol. Laryngol. 1998; 107: 671-4.
33. Jackson KR, Jackson RT. Factors associated with active, refractory epistaxis. Arch. Otolaryngol. Head Neck Surg. 1988; 114: 862-5.
34. Sandoval C, Dong S, Visintainer P, Ozkaynak MF, Jayabose S. Clinical and laboratory features of 178 children with recurrent epistaxis. J. Ped. Hematol. Oncol. 2002; 24: 47-9.
35. Krempl GA, Noorily AD. Use of oxymetazoline in the management of epistaxis. Ann. Otol. Rhinol. Laryngol. 1995; 104: 704-6.
36. Ruddy J, Proops DW, Pearman K, Ruddy H. Management of epistaxis in children. Int. J. Ped. Otorhinolaryngol. 1991; 21: 139-42.
37. Toner JG, Walby AP. Comparison of electro and chemical cautery in the treatment of anterior epistaxis. J. Laryngol. Otol. 1990; 104: 617-18.
38. Murthy P, Nilssen EL, Rao S, McClymont LG. A randomised clinical trial of antiseptic nasal carrier cream and silver nitrate cautery in the treatment of recurrent anterior epistaxis. Clin. Otolaryngol. 1999; 24: 228-31.
39. Kubba H, Macandie C, Botma M et al. Antiseptic cream for recurrent epistaxis in children: a prospective, single-blind, randomized controlled trial. Clin. Otolaryngol. 2003; 28: 160.
40. Burton MJ, Doree CJ. Interventions for recurrent idiopathic epistaxis (nosebleeds) in children. Cochrane Ear, Nose and Throat Disorders Group. Cochrane Database of Systematic Reviews 2004; 2.
41. Pringle MB, Beasley P, Brightwell AP. The use of Merocel nasal packs in the treatment of epistaxis. J. Laryngol. Otol. 1996; 110: 543-6.
42. McGlashan JA, Walsh R, Dauod A, Vowles A, Gleeson MJ. A comparative study of calcium sodium alginate (Kaltostat) and bismuth tribromophenate (Xeroform) packing in the management of epistaxis. J. Laryngol. Otol. 1992; 106: 1067-71.
43. Murthy P, Christodoulou C, Yatigammana N, Datoo M. The influence of medical audit on the management of epistaxis in three district general hospitals. J. Laryngol. Otol. 1994; 108: 38-41.
44. Corbridge RJ, Djazaeri B, Hellier WPL et al. A prospective randomized controlled trial comparing the use of Merocel nasal tampons and BIPP in the control of acute epistaxis. Clin. Otolaryngol. 1995; 20: 305-7.
45. McFerran DJ, Edmonds SE. The use of balloon catheters in the treatment of epistaxis. J. Laryngol. Otol. 1993; 107: 197-200.
46. Holland NJ, Sandhu GS, Ghufoor K, Frosh A. The Foley catheter in the management of epistaxis. Int. J. Clin. Pract. 2001; 55: 14-15.
47. Derkay CS, Hirsch BE, Johnson JT, Wagner RL. Posterior nasal packing; are intravenous antibiotics really necessary? Arch. Otolaryngol. Head Neck Surg. 1989; 115: 439-41.
48. Monte ED, Belmont MJ, Wax MK. Management paradigms for posterior epistaxis: a comparison of costs and complications. Otolaryngol. Head Neck Surg. 1999; 121: 103-6.
49. Vaiman M, Segal S, Eviatar E. Fibrin glue treatment for epistaxis. Rhinology 2002; 40: 88-91.
50. Walshe P. The use of fibrin glue to arrest epistaxis in the presence of a coagulopathy. Laryngoscope 2002; 112: 1126-8.
51. Sabba C, Gallitelli M, Palasciano G. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia. N. Engl. J. Med. 2001; 345: 926.
52. White A, O'Reilly BF. Oral tranexamic acid in the management of epistaxis. Clin. Otolaryngol. 1988; 13: 11-16.
53. Tibbelin A, Aust R, Bende M et al. Effect of local tranexamic acid gel in the treatment of epistaxis. J. Oto. Rhin. Laryngol. 1995; 57: 207-9.
54. Mirza S, Counter P, Johnson IJM. Tranexamic acid for epistaxis (nosebleeds). [Protocol] Cochrane Database of Systematic Reviews 2004; 2.
55. Bharadwaj VK. Greater palatine canal injection. J. Otolaryngol. 1986; 15: 94-100.